Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
92.41
(
0.00%
)
Bitcoin
73,621.91
(
0.88%
)
News Focus
News Focus
Post# of 257382
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11875
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: DewDiligence post# 234131

Saturday, 08/08/2020 6:47:21 PM

Saturday, August 08, 2020 6:47:21 PM

Post# of 257382
The API manufacturing setting isn't nearly as bad today as it was 20 years ago.

Manufacturing bulk API in the U.S. is not profitable mainly because of Labor and effluent costs.

PR would be an ideal place because of all the abandoned Drug Manufacturing facilities. They also could easily hire personnel who previously worked in Pharma. Enormous.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today